Core Viewpoint - The company, New Wave Pharmaceuticals (06108), has announced a placement agreement to issue up to 33.432 million shares at a price of HKD 0.225 per share, which represents a discount to the market price [1] Group 1: Placement Details - The placement will be made to at least six independent third-party investors [1] - The maximum number of shares to be placed represents approximately 20.00% of the company's existing issued share capital as of the announcement date, and about 16.66% of the enlarged issued share capital post-placement [1] - The placement price of HKD 0.225 per share reflects an 8.16% discount to the last closing price of HKD 0.245 and a 10.57% discount to the average closing price of HKD 0.2516 over the five trading days preceding the last trading day [1] Group 2: Financial Implications - The total gross proceeds from the placement are expected to be approximately HKD 7.5 million, with net proceeds estimated at around HKD 7.4 million after deducting placement fees and other expenses [1] - The net proceeds from the placement will be used entirely for acquiring additional distribution rights related to the company's core business [1]
新锐医药(06108)拟折让约8.16%配售最多3343.2万股配售股份 净筹约740万港元